Browse the detailed record of transactions filed by Lubniewski John L, Chairman & CEO. Insider active across 1 companies, notably HTG Molecular Diagnostics, INC. Aggregated, 13 disclosures have been recorded. The latest transaction was filed on 30 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
John L. Lubniewski is the President and CEO of HTG MOLECULAR DIAGNOSTICS, INC. He leads the company by implementing strategies aimed at improving performance and fostering innovation in the molecular diagnostics sector.